Arsenate V induced glutathione efflux from human erythrocytes

Journal of Trace Elements in Medicine and Biology

Volumn 26, Issue 1, 2012, Pages 53-58

  Yildiz, Deniz ^a   Cakir, Yeliz ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Arsenate; Glutathione; Human erythrocytes; Membrane transport

Indexed keywords

ARSENIC ACID; GLUTATHIONE; LACTATE DEHYDROGENASE; MULTIDRUG RESISTANCE PROTEIN 1; VERLUKAST;

ARTICLE; CELL LEVEL; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; SUPERNATANT; TRANSPORT KINETICS;

ARSENATES; ERYTHROCYTE COUNT; ERYTHROCYTES; GLUTATHIONE; HUMANS; HYDRO-LYASES; OXIDATION-REDUCTION;

EID: 84857801862     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2011.11.003     Document Type: Article

References (52)

1. Chiou H.Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 1995, 55:1296-1300.
2. Das D., Chatterjee A., Mandal B.K., Samanta G., Chakraborti D. Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people. Analyst 1995, 120:917-924.
3. Kersjes M.P., Maurer J.R., Trestrail J.H., McCoy D.J. An analysis of arsenic exposures referred to the Blodgett Regional Poison Center. Vet Hum Toxicol 1987, 29:75-78.
4. Kelafant G.A., Kasarskis E.J., Horstman S.W., Cohen C., Frank A.L. Arsenic poisoning in central Kentucky: a case report. Am J Ind Med 1993, 24:723-726.
5. Kingston R.L., Hall S., Sioris L. Clinical observations and medical outcome in 149 cases of arsenate ant killer ingestion. Clin Toxicol 1993, 31:581-591.
6. Chan P.C., Huff J. Arsenic carcinogenesis in animals and in humans: mechanistic, experimental, and epidemiological evidence. Environ Carcinog Ecotoxicol Rev 1997, 15:83.
7. Iffland R. Arsenic. Handbook on metals in clinical and analytical chemistry 1994, 237-253. Marcel Dekker, New York. H.G. Seiler, A. Sigel, H. Sigel (Eds.).
8. Ishinishi N., Tsuchiya K., Vahter M., Fowler B.A. Arsenic. Handbook on the toxicology of metals 1986, 133:43-83. Elsevier, New York. 2nd ed.
9. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol Lett 2002, 133(1):1-16.
10. Dixon H.B.F. The biochemical action of arsonic acids, especially as phosphate analogues. Adv Inorg Chem 1977, 44:191-227.
11. Nordenson I., Beckman L. Is the genotoxic effect of arsenic mediated by oxygen free radicals. Hum Hered 1991, 41:71-73.
12. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., et al. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem Res Toxicol 2004, 17(7):871-878.
13. Ding W., Hudson L.G., Liu K.J. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol. Cell Biochem 2005, 279(1-2):105-112.
14. Lantz C.R., Hays A.M. Role of oxidative stress in arsenic-induced toxicity. Drug Metab Rev 2006, 38(4):791-804.
15. Winski S.L., Carter D.E. Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J Toxicol Environ Health 1995, 46(3):379-397.
16. Healy S.M., Wildfang E., Zakharyan R.A., Aposhian H.V. Diversity of inorganic arsenite biotransformation. Biol Trace Elem Res 1999, 68:249-266.
17. Nemeti B., Gregus Z. Glutathione-dependent reduction of arsenate in human erythrocytes-a process independent of purine nucleoside phosphorylase. Toxicol Sci 2004, 82(2):419-428.
18. Bertolero F., Pozzi G., Sabbioni E., Saffiotti U. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants cytotoxicity and morphological transformation. Carcinogenesis 1987, 8:803-808.
19. Musallam L., Ethier C., Haddad P.S., Denizeau F., Bilodeau M. Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture. Am J Physiol Gastrointest Liver Physiol 2002, 283:G709-G718.
20. Pullar J.M., Hampton M.B. Diphenyleneiodonium triggers the efflux of glutathione from cultured cells. J Biol Chem 2002, 277(22):19402-19407.
21. He Y.Y., Huang J.L., Ramirez D.C., Chignell C.F. Role of reduced glutathione efflux in apoptosis of immortalized human keratinocytes induced by UVA. J Biol Chem 2003, 278(10):8058-8064.
22. Franco R., Cidlowski J.A. SLCO/OATP-like transport of glutathione in FasL-induced apoptosis. Glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J Biol Chem 2006, 281(40):29542-29557.
23. Rothnie A., Callaghan R., Deeley R.G., Cole S.P.C. Role of GSH in estrone sulfate binding and translocation by the multidrug resistance protein 1 (MRP1/ABCC1). J Biol Chem 2006, 281(20):13906-13914.
24. Loe D.W., Deeley R.G., Cole S.P.C. Characterization of vincristine transport by the Mr 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. Cancer Res 1998, 58:5130-5136.
25. Nemeti B., Csanaky I., Gregus Z. Arsenate reduction in human erythrocytes and rats-testing the role of purine nucleoside phosphorylase. Toxicol Sci 2003, 74:22-31.
26. Winski S.L., Carter D.E. Arsenate toxicity in human erythrocytes: characterization of morphologic changes and determination of the mechanism of damage. J Toxicol Environ Health A 1998, 53(5):345-355.
27. Zhanga T.L., Gaob Y.X., Luc J.F., Wang K., Arsenite arsenate and vanadate affect human erythrocyte membrane. J Inorg Biochem 2000, 79(1-4):195-203.
28. Sedlak J., Lindsay R.H. Determination of sulfhydryl groups in biological samples. Anal Biochem 1963, 25:192-205.
29. Welder A.A., Acosta D. Enzyme leakage as an indicator of cytotoxicity in cultured cells. Methods Toxicol 1994, 18:46-49.
30. Berner W., Kinne R., Murer H. Phosphate transport into brush-border membrane vesicles isolated from rat small intestine. Biochem J 1976, 160:467-474.
31. Ginsburg J.M., Lotspeich W.D. Interrelations of arsenate and phosphate transport in the dog kidney. Am J Physiol 1963, 205:707-714.
32. +-dependent transport of phosphate across renal brush border membrane. J Biol Chem 1986, 261:6375-6383.
33. Nemeti B., Gregus Z. Reduction of arsenate to arsenite by human erythrocyte lysate and rat liver cytosol-characterization of a glutathione- and NAD-dependent arsenate reduction linked to glycolysis. Toxicol Sci 2005, 85(2):847-858.
34. Braman R.S., Foreback C.C. Methylated forms of arsenic in the environment. Science 1973, 182(4118):1247-1249.
35. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., et al. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 2000, 13(8):693-697.
36. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 2001, 14(4):371-378.
37. Suzuki K.T., Tomita T., Ogra Y., Ohmichi M. Glutathione-conjugated arsenics in the potential hepato-enteric circulation in rats. Chem Res Toxicol 2001, 14(12):1604-1611.
38. Kala S.V., Neely M.W., Kala G., Prater C.I., Atwood D.W., Rice J.S., et al. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 2000, 275(43):33404-33408.
39. Hayakawa T., Kobayashi Y., Cui X., Hirano S. A new metabolic pathway of arsenite: arsenic-glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 2005, 79(4):183-191.
40. Naranmandura H., Suzuki N., Suzuki K.T. Trivalent arsenicals are bound to proteins during reductive methylation. Chem Res Toxicol 2006, 19(8):1010-1018.
41. Thomas D.J., Li Jiaxin, Waters S.B., Xing W., Adair B.M., Drobna Z., et al. Arsenic (+3 oxidation state) methyltransferase and the methylation of arsenicals. Exp Biol Med 2007, 232(1):3-13.
42. Abraham M.I., Burckhardt G., Kempson S.A. Sodium-dependent phosphate transport in a rat kidney endosomal fraction. Kidney Int 1992, 42:1070-1078.
43. Delnomdedieu M., Basti M.M., Styblo M., Otvos J.D., Thomas D.J. Complexation of arsenic species in rabbit erythrocytes. Chem Res Toxicol 1994, 7:621-627.
44. Shoemaker D.G., Bender C.A., Gunn R.B. Sodium-phosphate cotransport in human red blood cells. Kinetics and role in membrane metabolism. J Gen Physiol 1988, 92:449-474.
45. 4 cotransporter is the molecular mechanism for Na/Li exchange in human red blood cells. Am J Physiol Cell Physiol 2003, 285:C446-C456.
46. Kondo T., Dale G.L., Beutler E. Glutathione transport by inside-out vesicles from human erythrocytes. Proc Natl Acad Sci USA 1980, 77(11):6359-6362.
47. Anundi I., Hogberg J., Vahter M. GSH release in bile as influenced by arsenite. FEBS Lett 1982, 145(2):285-288.
48. Gyurasics A., Varga F., Gregus Z. Glutathione-dependent biliary excretion of arsenic 1991, 42(3):465-468.
49. Huang R.N., Lee T.C. Arsenite efflux is inhibited by verapamil, cyclosporin A, and GSH-depleting agents in arsenite-resistant Chinese hamster ovary cells. Toxicol Appl Pharmacol 1996, 141(1):17-22.
50. Zaman G.J.R., Lankelma J., Tellingen O.V., Beijnens J., Dekker H., Paulusma C., et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 1995, 92:7690-7694.
51. Salerno M., Petroutsa M., Suillerot A.G. The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation. J Bioenerg Biomembr 2002, 34(2):135-145.
52. Leslie E.M., Haimeur A., Waalkes M.P. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required. Biol Chem 2004, 279(31):32700-32708.